Darbų medis, UAB - financials and debts

Company age: 7 y. 6 mo.

Update

Darbų medis - Company finances

EUR
2019
From: 2019-03-07
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 17,029 63,047 46,748 381,069 177,535 491,671 379,867
Profit before tax - - - - 18,643 8,557 14,491
Net profit -16,516 -5,853 -29,558 85,127 17,581 6,651 8,908
Equity -14,016 -30,344 -59,410 25,717 43,298 49,950 58,859
Liabilities 17,228 36,912 67,066 74,035 135,525 376,235 408,245
Non-current assets 1,574 1,457 1,341 4,193 3,455 264,047 239,462
Current assets 1,638 0 6,315 95,559 175,368 186,543 250,106
Total assets 3,212 1,457 7,656 99,752 178,823 450,590 489,568
Taxes paid
STI taxes - - - - - - 4,460
Social insurance contributions - - - - 14,813 14,446 9,514
Financial indicators
Revenue change y/y - +270.2% -25.9% +715.2% -53.4% +176.9% -22.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -514.2% -401.7% -386.1% 85.3% 9.8% 1.5% 1.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - 331.0% 40.6% 13.3% 15.1%
Profit margin Net profit margin. Shows the overall profitability of the company. -97.0% -9.3% -63.2% 22.3% 9.9% 1.4% 2.3%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - 10.5% 1.7% 3.8%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - 2.9 3.1 7.5 6.9
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 5,676 13,756 8,904 73,755 26,630 64,836 79,972

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Darbų medis - Social security debts

From To Debt, €
2026-05-17 2026-05-21 289.43
2026-05-04 2026-05-14 1.49
2026-05-03 2026-05-03 2.87
2026-04-27 2026-04-29 1.38
2026-04-24 2026-04-26 2.87
2026-04-23 2026-04-23 1.49
2026-02-18 2026-02-22 0.76
2026-01-22 2026-02-04 0.76
2026-01-21 2026-01-21 734.60
2026-01-16 2026-01-20 733.94
2025-10-23 2025-11-04 0.97
2025-10-16 2025-10-19 580.06
2025-08-28 2025-08-29 215.29
2025-08-19 2025-08-25 215.29
2025-07-24 2025-08-12 0.28
2025-07-16 2025-07-23 215.29
2025-06-17 2025-06-22 214.21
2025-05-16 2025-06-02 0.29
2025-05-04 2025-05-07 0.29
2025-04-24 2025-04-29 0.29
2025-02-18 2025-02-20 268.78
2024-11-18 2024-11-18 61.28
2024-09-17 2024-09-26 1268.80
2024-06-18 2024-07-07 41.24
2024-05-16 2024-05-19 1165.78
2024-04-23 2024-05-15 12.61
2024-03-18 2024-03-27 592.77
2024-02-29 2024-03-04 826.38
2024-02-28 2024-02-28 873.89
2024-02-19 2024-02-27 1389.96
2024-01-31 2024-02-01 136.61
2024-01-23 2024-01-30 214.59
2024-01-22 2024-01-22 1031.04
2024-01-16 2024-01-21 1597.77
2024-01-15 2024-01-15 1.84
2023-12-18 2024-01-11 1.84
2023-11-16 2023-12-12 1.84
2023-10-27 2023-11-12 1.84
2023-10-25 2023-10-25 1.84
2023-10-17 2023-10-24 1359.65
2023-08-17 2023-09-10 10.99
2023-07-24 2023-07-24 0.31
2023-07-18 2023-07-23 871.43
2022-10-28 2022-11-07 0.30

Darbų medis - VMI tax arrears

From To Overdue, €
2026-03-19 2026-03-24 0.2
2026-03-02 2026-03-02 10108.08
2026-01-14 2026-01-19 1.65
2026-01-01 2026-01-13 407.57
2025-11-20 2025-11-25 236.35
2025-09-19 2025-09-25 4.35

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Darbu medis, UAB (company code 305067397) is a private limited liability company engaged in construction of other civil engineering projects n.e.c. In the latest financial year, 2025, the company generated EUR 379.9K in revenue and EUR 8.9K in net profit, corresponding to a profit margin of 2.4%. Revenue declined by 22.7% year on year from EUR 491.7K in 2024, but remained well above the 2023 level of EUR 177.5K, indicating a strong two-year expansion of 114.0%. Profitability also remained positive across the period, although net profit fell from EUR 17.6K in 2023 to EUR 6.7K in 2024 before improving to EUR 8.9K in 2025. At the end of 2025, total assets stood at EUR 489.6K, equity at EUR 58.9K and liabilities at EUR 408.2K. The equity ratio was 12.0% and debt-to-equity 6.94, reflecting a leveraged balance sheet. Asset turnover was 0.78x, ROE 15.1% and ROA 1.8%. Revenue per employee reached EUR 95.0K, with profit per employee of EUR 2.2K.